U.S. Transportation Stock News

NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork (UPWK) Margin Compression To 14.7% Tests Bullish Undervaluation Narrative

Upwork (UPWK) has just wrapped FY 2025 with fourth quarter revenue of US$198.4 million and basic EPS of US$0.12, alongside net income of US$15.6 million. This rounds out a year where trailing twelve month revenue came in at US$787.8 million and EPS at US$0.87. Over recent quarters the company has seen revenue move from US$191.5 million in Q4 2024 to between US$192.7 million and US$201.7 million across FY 2025, while quarterly EPS has ranged from US$0.12 to US$0.28. This sets up a story that...
NYSE:NET
NYSE:NETIT

Cloudflare (NET) Q4 Loss Narrows Yet Ongoing TTM Losses Test Bullish Profitability Narrative

Cloudflare FY 2025 earnings snapshot Cloudflare (NET) has wrapped up FY 2025 with fourth quarter revenue of US$614.5 million and basic EPS of a US$0.03 loss, alongside a trailing twelve month revenue base of about US$2.2 billion and a net loss of US$102.3 million. Over recent periods the company has seen revenue move from US$430.1 million in Q3 2024 to US$614.5 million in Q4 2025, while quarterly basic EPS has ranged between a loss of US$0.15 and a loss of US$0.00, underscoring an ongoing...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Will Caesars’ Narrowed Loss and New Venues Reshape Caesars Entertainment's (CZR) Investment Narrative?

In the first quarter of 2026, Caesars Entertainment reported higher sales of US$2,153 million and revenue of US$2,870 million, while reducing its net loss to US$98 million compared with the prior year. Alongside these improved results, Caesars has been expanding its entertainment offerings with new venues such as OMNIA Dayclub & Skybar in Las Vegas and the upcoming Caesars Beach Club in Atlantic City, aiming to draw more visitors to its properties. Next, we will examine how Caesars’ narrowed...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Does Milestone-Driven Profit Shift the Bull Case For Protagonist Therapeutics’ New Model (PTGX)?

Protagonist Therapeutics reported first-quarter 2026 results that swung to a net income of US$3.78 million, helped by a US$50 million milestone payment linked to FDA approval of ICOTYDE and a US$200 million payment from restructuring its rusfertide collaboration. These developments not only produced an unexpected profit but also shifted Protagonist’s business model toward milestone- and royalty-based revenues backed by liquidity of about US$620.3 million. Next, we’ll examine how this move...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Is It Time To Reassess Adobe (ADBE) After Its Recent Share Price Slump?

If you are wondering whether Adobe's current share price really reflects what the stock could be worth, this breakdown will help you weigh up the numbers behind that question. Adobe closed at US$256.51, with returns of 4.2% over the last week and 6.8% over the last month, while the year-to-date return stands at a 23.0% decline and the 1-year return at a 33.2% decline. Recent moves in the stock sit alongside ongoing attention on Adobe's position in creative software and digital media, as...
NYSE:RKT
NYSE:RKTDiversified Financial

Rocket Companies (RKT) Swings To Q4 Profit And Tests Bullish Turnaround Narrative

Rocket Companies (RKT) closed FY 2025 with fourth quarter revenue of US$2.8b, basic EPS of US$0.02 and net income of US$68.0m, setting a clear marker for how the year wrapped up. Over recent periods the company has seen quarterly revenue move from US$1.9b in Q4 2024 to US$2.8b in Q4 2025, while basic EPS shifted from US$0.23 to US$0.02, and net income moved from US$33.5m to US$68.0m. This provides a clear view of how the top and bottom lines translated into current margins and overall...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Innodata (INOD) Margin Compression Challenges Bullish AI Growth Narrative After FY 2025 Results

Innodata (INOD) just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, while trailing twelve month revenue came in at US$251.7 million and basic EPS at US$1.01. Over recent quarters the company has seen revenue move from US$59.2 million in Q4 2024 to US$72.4 million in Q4 2025, with basic EPS shifting from US$0.34 to US$0.28 over the same period. This sets up a picture where growth expectations and margin trends will be front of mind for investors...
NYSE:MRP
NYSE:MRPSpecialized REITs

Is It Time To Reassess Millrose Properties (MRP) After The Recent Share Price Pullback

If you are wondering whether Millrose Properties at around US$26.90 still offers value, the starting point is to understand what the current price implies about the business. The stock is up 14.1% over the last year, even though it has seen a 12.3% decline over the past week and a 3.0% decline over the past month, with a 9.8% decline year to date. This may have shifted how some investors think about its risk and reward trade off. Recent coverage has focused on Millrose Properties as a...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Capital Clean Energy Carriers TTM Margin Surge Challenges Bearish Narratives On Profit Durability

Capital Clean Energy Carriers (CCEC) has just wrapped up FY 2025 with fourth quarter revenue of US$86.8 million and basic EPS of US$0.46. Trailing 12 month EPS came in at US$1.92 as earnings over that period were very large compared with the prior year. The company has seen revenue on a trailing 12 month basis move from US$339.5 million in FY 2024 to US$392.7 million in FY 2025. Over the same period, EPS shifted from US$0.13 to US$1.92 and net profit margin moved from 2.2% to 28.9%. These...
NYSE:GNW
NYSE:GNWInsurance

How Genworth’s Buybacks, Enact and CareScout Build-Out At Genworth Financial (GNW) Has Changed Its Investment Story

Genworth Financial reported past first-quarter 2026 results with revenue of US$1,777 million and net income of US$47 million, alongside modestly lower earnings per share year over year. The company also completed a sizeable share repurchase program and highlighted Enact’s contribution and the build-out of CareScout as key parts of its longer-term plan. Next, we will examine how Genworth’s continued share repurchases shape the company’s investment narrative and its appeal to different...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

Is Dentsply Sirona (XRAY) Now Offering Value After A 28% One Year Share Price Slide

If you are wondering whether DENTSPLY SIRONA stock is starting to look interesting at current levels, its recent price and valuation signals give you a lot to think about. The share price sits at US$10.96 after a 6.7% decline over the last week, a 4.9% decline over the last month and a 28.5% decline over the last year, which may change how you view both its risk and potential reward. Recent coverage around DENTSPLY SIRONA has focused on its position within the medical equipment space and how...
NYSE:CR
NYSE:CRMachinery

A Look At Crane (CR) Valuation After Q1 Beat Guidance Lift And Margin Pressure

What Crane’s latest earnings and M&A comments mean for investors Crane (CR) just paired a Q1 earnings beat with a slight uptick in full year adjusted EPS guidance, yet a softer operating margin and active acquisition agenda are shaping how investors reassess the stock. See our latest analysis for Crane. Crane’s recent Q1 earnings beat, slight full year EPS guidance increase, dividend affirmation, and active M&A commentary come after a 1 year total shareholder return of 7.6%. The 3 year total...
NYSE:MTD
NYSE:MTDLife Sciences

Mettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives

Mettler-Toledo International (MTD) closed out FY 2025 with fourth quarter revenue of US$1,129.7 million and basic EPS of US$14.02, setting the tone for a year where trailing twelve month revenue reached US$4.0 billion and EPS came in at US$42.17. Over recent quarters the company has seen revenue move from US$954.5 million in Q3 2024 to US$1,129.7 million in Q4 2025, while quarterly EPS stepped from US$10.01 to US$14.02. This has left investors focused on how these trends flow through to...
NYSE:MIAX
NYSE:MIAXCapital Markets

Is It Too Late To Consider Miami International Holdings (MIAX) After Recent Share Price Gains?

If you are wondering whether Miami International Holdings at around US$49.77 is priced attractively or not, the key question is how that tag compares with what the business could reasonably be worth. Over shorter periods, the stock has been active, with returns of 7.1% over the last 7 days, 20.5% over the last 30 days and 14.0% year to date, which hints that expectations and perceived risk are shifting. Recent coverage has focused on Miami International Holdings as part of broader...
NYSE:SES
NYSE:SESElectrical

SES AI Shifts Toward Defense And Storage With New Contracts And AI

SES AI (NYSE:SES) has converted its South Korea facility to produce NDAA-compliant drone battery cells for defense customers. The company signed a multi-year, $20 million distribution agreement with ATG EPower for North American energy storage systems. SES AI is applying AI tools to optimize defense-focused battery products, expanding its use of the technology beyond R&D. SES AI, trading at about $0.921 per share, is shifting focus beyond long-cycle EV battery development toward products...
NasdaqGS:KHC
NasdaqGS:KHCFood

Is It Time To Rethink Kraft Heinz (KHC) After Its Recent Share Price Slide

If you are wondering whether Kraft Heinz is a bargain or a value trap at around US$23.66, this article breaks down what that price really implies for you. The stock has recently returned 4.4% over the last week and 2.1% over the last month, yet is still showing a 3.0% decline year to date and an 11.7% decline over the past year. Recent coverage has focused on Kraft Heinz as a mature packaged food giant that investors often look to for stability, which can attract attention when prices move...
NYSE:AGL
NYSE:AGLHealthcare

Is It Too Late To Consider Agilon Health (AGL) After Its Recent 260% Rally?

Wondering whether agilon health’s recent action has left the stock looking expensive or still potentially mispriced? This article breaks down what the current price might be implying about its value. The stock last closed at US$60.66, with returns of 117.0% over 7 days, 265.6% over 30 days and 260.2% year to date. The 1 year and 3 year returns stand at negative 24.6% and negative 90.4% respectively. These sharp moves are drawing attention back to agilon health, especially as investors weigh...
NYSE:STT
NYSE:STTCapital Markets

Is It Too Late To Consider State Street (STT) After A 62.6% One Year Surge?

Wondering if State Street stock still offers value after a strong run, or if most of the opportunity is already reflected in the price? This article focuses squarely on what you are paying for each dollar of fundamentals. At a recent close of US$148.78, the stock has returned 13.4% over the past month, 15.3% year to date, and 62.6% over the last year, with a 2.7% decline in the last week and longer term 3 year and 5 year returns of 142.5% and 103.6%. Recent headlines around large financial...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio-Techne (TECH): Do Steady Dividends Amid Soft Sales Reveal Its True Capital Allocation Priorities?

Bio-Techne Corporation reported its fiscal third-quarter 2026 results in early May, with net sales of US$311.42 million, a 2% year-over-year decline, while net income rose to US$51.05 million and diluted EPS from continuing operations increased to US$0.32. Alongside softer demand from emerging biotech customers and shipment timing issues that weighed on revenue, Bio-Techne’s profitability improved and the Board affirmed a quarterly cash dividend of US$0.08 per share, highlighting an ongoing...
NYSE:BG
NYSE:BGFood

Is It Too Late To Consider Bunge Global (BG) After Its Strong 1 Year Rally?

Wondering if Bunge Global is reasonably priced after a strong run, or if the stock might already reflect a lot of good news? This article focuses squarely on what you are paying versus what you might be getting. The stock most recently closed at US$123.75, with a 33.6% year to date return and a 67.3% return over 1 year, following a 2.6% decline over both the last 7 days and the last 30 days. Recent coverage has highlighted Bunge Global's role in the global food and agriculture supply chain,...
NYSE:GXO
NYSE:GXOLogistics

Is It Time To Reassess GXO Logistics (GXO) After Recent Share Price Pullback?

Wondering if GXO Logistics at around US$51.88 is offering you value right now, or if the recent price action has already reflected most of the upside? The stock has pulled back, with a 9.2% decline over the last week and a 2.6% decline over the last month, while the 1 year return sits at 30.6% and the 3 year return at a 4.9% decline. Recent coverage has focused on how GXO Logistics fits into broader logistics and supply chain themes, as investors reassess the sector after a strong 1 year...